Actively Recruiting
Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer
Led by ARCAGY/ GINECO GROUP · Updated on 2024-10-28
327
Participants Needed
24
Research Sites
55 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to understand whether it is possible to predict the effectiveness of maintenance treatment with PARP inhibitors following first-line chemotherapy in ovarian cancer, and thus better target the patients who benefit from this treatment
CONDITIONS
Official Title
Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients randomized in the PAOLA-1 study
You will not qualify if you...
- Opposition to the use of your data for research purposes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 24 locations
1
ICO Paul Papin
Angers, France, 49055
Actively Recruiting
2
Sainte-Catherine Institut du Cancer Avignon-Provence
Avignon, France, 84918
Actively Recruiting
3
CHRU Besançon - Hôpital Jean Minjoz
Besançon, France, 25030
Actively Recruiting
4
Polyclinique Bordeaux Nord
Bordeaux, France, 33300
Actively Recruiting
5
Centre François Baclesse
Caen, France, 14076
Actively Recruiting
6
Centre Jean Perrin
Clermont-Ferrand, France, 63011
Actively Recruiting
7
CHU Grenoble-Alpes - Site Nord (La Tronche)
Grenoble, France, 38043
Actively Recruiting
8
Centre Hospitalier Départemental de Vendée
La Roche-sur-Yon, France, 85925
Actively Recruiting
9
Centre Azuréen de Cancérologie
Mougins, France, 06250
Actively Recruiting
10
Hôpital Privé du Confluent
Nantes, France
Actively Recruiting
11
Groupe Hospitalier Diaconesses - Croix Saint-Simon
Paris, France, 75012
Actively Recruiting
12
Hôpital Cochin
Paris, France, 75014
Actively Recruiting
13
Hôpital Européen Georges Pompidou
Paris, France, 75015
Actively Recruiting
14
Institut Curie
Paris, France, 75248
Actively Recruiting
15
Clinique Francheville
Périgueux, France, 24004
Actively Recruiting
16
HCL - Centre Hospitalier Lyon Sud
Pierre-Bénite, France, 69495
Actively Recruiting
17
CHU de Poitiers - Hôpital de la Milétrie
Poitiers, France, 86021
Actively Recruiting
18
Centre Eugène Marquis
Rennes, France, 35042
Actively Recruiting
19
ICO - Centre René Gauducheau
Saint-Herblain, France, 44805
Actively Recruiting
20
Oncopole Claudius Regaud - IUCT Oncopole
Toulouse, France, 31059
Actively Recruiting
21
Clinique Pasteur
Toulouse, France, 31300
Actively Recruiting
22
ICL - Centre Alexis Vautrin
Vandœuvre-lès-Nancy, France, 54519
Actively Recruiting
23
Gustave Roussy
Villejuif, France, 94805
Actively Recruiting
24
Centre Hospitalier Princesse Grace
Monaco, Monaco, 98012
Actively Recruiting
Research Team
S
Sandra MABALUKIDI
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here